DAIDS Regulatory Support Center Logo Secure DAIDS RCC Document Collaboration Site Web Site Feedback
Home | About the RSC | Frequently Asked Questions | Contact Information | Useful Links | Web Site Update Log
Broadcast Memos
DAIDS RSC Presentations
Regulatory Information
Protocol Development Information
Human Subjects Protection (HSP)
Protocol Registration
Safety and Pharmacovigilance
Case Report Form
(CRF) Management
Clinical Study
Information Office
Regulatory Information

What does the DAIDS/RSC Regulatory team do?

The Regulatory Team reviews Protocol Documents for regulatory compliance, and prepares and files new Investigation New Drug Applications (INDs) and amendments to existing INDs in compliance with the procedural and substantive requirements of 21 CFR ยง 312. Examples of submissions to the FDA include original IND Applications, Annual Reports, Safety Reports, and Responses to FDA Requests for Information.


Bullet Regulatory Guidance - DAIDS HIPAA Policy Adobe PDF Document

Bullet DAIDS Policy # DWD-POL-CL-013.03, Expedited Adverse Event Reporting, dated 28 April 2010 Adobe PDF Document

Bullet Latest DAIDS Policies and SOPs Web Site Link

Bullet National Institutes of Health (NIH)
 


  • NIH Revitalization Act of 1993
Web Site Link



  • NIH Brochure - Research on Human Specimens
Web Site Link



  • Guidance on Data and Safety Monitoring for Phase I and II Trials
Web Site Link



  • Notice to Grantees/Contractors re: FDA-NIH Interaction
Web Site Link



  • Guidelines on Inclusion of Women/Minorities as Clinical Research Subjects
Web Site Link



  • Required Education in Protection of Human Research Participants
Web Site Link

Bullet IND and Clinical Research Regulations and Guides
 


  • 21 CFR Part 312 - Investigational New Drug Application
Web Site Link



  • 21 CFR Part 312.32 - IND Safety Reports
Web Site Link



  • 21 CFR Part 54 - Financial Disclosure by Clinical Investigators
Web Site Link



  • FDA Information Sheets - Guidance for Institutional Review Boards and Clinical Investigators
Web Site Link



  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) - Good Clinical Practice
Web Site Link

Bullet Human Subjects Protection
 


  • The Belmont Report
Web Site Link



  • 21 CFR Part 50 - Protection of Human Subjects
Web Site Link



  • 45 CFR Part 46--Protection of Human Subjects
Web Site Link



  • 2003 - Certificates of Confidentiality
Web Site Link



  • 2003 - Guidance on Approving Research Involving Prisoners
Web Site Link



  • 1997 - Storage of Tissue/Cell Repositories
Web Site Link



  • 1988 - PHS Policy on Informing Those Tested About HIV Serostatus
Web Site Link



  • 1984 - Guidance for Institutional Review Boards for AIDS Studies
Web Site Link

Document Title Search

Search Help
RSC Quick Contacts
Package Inserts
Investigator Brochures
Website Change Form
 
Latest News & Updates